Shelley Bausch was appointed as Class II director at INNOSPEC INC..
“appointed Shelley Bausch to serve as a Class II director of the Company starting as of July 1, 2026”
INNOSPEC INC. — fact timeline
Source-grounded facts extracted from INNOSPEC INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
INNOSPEC INC. shareholders approved Ratification of the appointment of the Company's independent registered public accounting firm for 2026 at the 2026-05-08 meeting.
“Proposal 3—Ratification of the appointment of the Company’s independent registered public accounting firm for 2026 The proposal on the ratification of the appointment of the Company’s independent registered public accounting firm for 2026 was approved. For: 22,642,171 Withheld: 14,676 Abstain: 4,337”
INNOSPEC INC. shareholders approved Advisory approval of the Company's executive compensation at the 2026-05-08 meeting.
“Proposal 2 – Advisory approval of the Company’s executive compensation The proposal on the Company’s executive compensation was approved. For: 20,171,691 Withheld: 860,992 Abstain: 29,823 Broker Non-Votes: 1,598,678”
INNOSPEC INC. shareholders approved Election of two Class I directors at the 2026-05-08 meeting.
“Proposal 1 – Election of two Class I directors All of the Class I directors were re-elected. Director Votes For Votes Withheld Broker Non-Votes Elizabeth K. Arnold 19,260,800 1,801,706 1,598,678 Claudia P. Poccia 19,670,078 1,392,428 1,598,678”
INNOSPEC INC. reported first quarter ended March 31, 2026 results: revenue $453.2 million, net income $30.4 million or $1.22 per diluted share, EPS $1.22 per diluted share.
“Total revenues for the first quarter were $453.2 million, an increase of 3 percent from $440.8 million in the corresponding period last year. Net income attributable to Innospec for the quarter was $30.4 million or $1.22 per diluted share compared to $32.8 million or $1.31 per diluted share recorded in the corresponding period last year.”
INNOSPEC INC. shareholders approved Ratification of the appointment of the Company’s independent registered public accounting firm for 2024 at the 2024-05-10 meeting.
“Proposal 3—Ratification of the appointment of the Company’s independent registered public accounting firm for 2024 For: 23,744,512 Withheld: 19,767 Abstain: 4,908”
INNOSPEC INC. shareholders approved Advisory approval of the Company’s executive compensation at the 2024-05-10 meeting.
“Proposal 2 – Advisory approval of the Company’s executive compensation For: 22,720,369 Withheld: 319,903 Abstain: 46,587 Broker Non-Votes: 682,328”
INNOSPEC INC. shareholders approved Election of two Class II directors at the 2024-05-10 meeting.
“At the annual meeting of Innospec shareholders held on May 10, 2024, the shareholders elected the directors nominated in the Innospec Proxy Statement, dated March 26, with the following votes for and votes withheld: Director Votes For Votes Withheld Broker Non-Votes Milton C. Blackmore 22,508,064 578,796 682,328 Leslie J. Parrette 20,473,042 2,613,818 682,328”
INNOSPEC INC. reported first quarter ended March 31, 2024 results: revenue $500.2 million, net income $41.4 million, EPS $1.65 per diluted share.
“Total revenues for the first quarter were $500.2 million, a decrease of 2 percent from $509.6 million in the corresponding period last year. Net income for the quarter was $41.4 million or $1.65 per diluted share compared to $33.2 million or $1.33 per diluted share recorded in the corresponding period last year.”
Philip Boon departed as Executive Vice President and Chief Operating Officer at INNOSPEC INC..
“On March 31, 2024, Dr. Philip Boon, Executive Vice President and Chief Operating Officer of Innospec Inc. (the “Company”), informed the Company of his decision to officially retire effective March 31, 2025.”
INNOSPEC INC. reported the fourth quarter and full year ended December 31, 2023 results: revenue $494.7 million, net income $37.8 million or $1.51 per diluted share, EPS $1.51 per diluted share.
“Innospec Inc. (NASDAQ: IOSP) today announced its financial results for the fourth quarter and full year ended December 31, 2023. Total revenues for the fourth quarter were $494.7 million, a decrease of 3 percent from $510.7 million in the corresponding period last year. Net income for the quarter was $37.8 million or $1.51 per diluted share compared to $25.5 million or $1.02 per diluted share recorded last year.”
INNOSPEC INC. reported the third quarter ended September 30, 2023 results: revenue $464.1 million, net income $39.2 million or $1.57 per diluted share, EPS $1.57 per diluted share.
“Total revenues for the third quarter were $464.1 million, a decrease of 10 percent from $513.0 million in the corresponding period last year. Net income for the quarter was $39.2 million or $1.57 per diluted share compared to $38.7 million or $1.55 per diluted share recorded last year.”
INNOSPEC INC. incurred revolving credit of $250,000,000 with various lenders at 1.25% added to the interest rate maturing May 30, 2027.
“lenders (the “Agreement”) which replaces the Company’s credit facility agreement dated September 26, 2019 (the “Pre-Existing Credit Agreement”). The Agreement provides for a $250,000,000 four-year multicurrency revolving loan facility available to the Borrowers (the “Facility”). The Agreement also contains an accordion feature whereby the Company may elect to”
INNOSPEC INC. entered into Multicurrency Revolving Facility Agreement with various lenders valued at $250,000,000 (effective 2023-05-31).
“On May 31, 2023, Innospec Inc. (the “Company”) and certain subsidiaries of the Company (together with the Company, the “Borrowers”) entered into a Multicurrency Revolving Facility Agreement with various lenders (the “Agreement”) which replaces the Company’s credit facility agreement dated September 26, 2019 (the “Pre-Existing Credit Agreement”). The Agreement provides for a $250,000,000 four-year multicurrency revolving loan facility available to the Borrowers (the “Facility”).”
Robert Paller departed as Director at INNOSPEC INC..
“On May 8, 2023, Robert Paller, a member of the Board of Directors (the “Board”) of Innospec Inc. (the “Company”), informed the Company of his decision not to stand for re-election to the Board when his current term as a director expires at the Company’s 2024 Annual Meeting of Stockholders (“Annual Meeting”).”
INNOSPEC INC. shareholders approved Ratification of the appointment of the Company's independent registered public accounting firm at the 2023-05-04 meeting.
“Proposal 4 – Ratification of the appointment of the Company’s independent registered public accounting firm: The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm: Auditors For: 23,854,177 Against: 23,472 Abstain: 8,531 Broker Non-Votes: 0”
INNOSPEC INC. shareholders approved Advisory approval of the Company's executive compensation at the 2023-05-04 meeting.
“Proposal 3 – Advisory approval of the Company’s executive compensation: The Company’s stockholders approved the advisory vote on the approval of the Company’s executive compensation: For: 22,174,236 Against: 817,808 Abstain: 13,688 Broker Non-Votes: 880,448”
INNOSPEC INC. shareholders approved Advisory vote on the frequency of the advisory vote on executive compensation at the 2023-05-04 meeting.
“Proposal 2 – Advisory vote on the frequency of the advisory vote on executive compensation: The Company’s stockholders approved the advisory vote on the frequency of the advisory vote on executive compensation : Frequency: 1 Year: 21,639,226 2 Years: 3,920 3 Years: 1,352,603 Abstain: 9,983 Broker Non-Votes: 880,448”
INNOSPEC INC. shareholders approved Election of two Class I Directors at the 2023-05-04 meeting.
“Proposal 1 – Election of two Class I Directors. The Company’s stockholders elected the following individuals to serve as Class I Directors of the Company: For: Withheld: Broker Non-Votes: Claudia P. Poccia 20,015,816 2,989,917 880,448 Elizabeth K. Arnold 22,406,421 599,312 880,448”
INNOSPEC INC. reported the fiscal quarter ended March 31, 2023 results: revenue $509.6 million, net income $33.2 million or $1.33 per diluted share, EPS $1.33 per diluted share.
“Total revenues for the first quarter were $509.6 million, an increase of 8 percent from $472.4 million in the corresponding period last year. Net income for the quarter was $33.2 million or $1.33 per diluted share compared to $36.5 million or $1.46 cents per diluted share recorded last year.”
INNOSPEC INC. reported financial results for the fiscal year ended December 31, 2022.
“On February 21, 2023 Innospec Inc. (the “Company”) issued a press release announcing its financial results for the fiscal year and quarter ended December 31, 2022 (the “Press Release”).”
INNOSPEC INC. reported the fourth quarter ended December 31, 2022 results: revenue $510.7 million, net income $25.5 million, EPS $1.02 per diluted share.
“Total revenues for the fourth quarter were $510.7 million, an increase of 24 percent from $413.2 million in the corresponding period last year. Net income for the quarter was $25.5 million or $1.02 per diluted share compared to $23.9 million or 96 cents per diluted share recorded last year.”
INNOSPEC INC. reported third quarter ended September 30, 2022 results: revenue $513.0 million, net income $38.7 million or $1.55 per diluted share, EPS $1.55 per diluted share.
“Total revenues for the third quarter were $513.0 million, an increase of 36 percent from $376.1 million in the corresponding period last year. Net income for the quarter was $38.7 million or $1.55 per diluted share compared to $23.4 million or 94 cents per diluted share recorded last year.”
Leslie J. Parrette was appointed as Class II Director at INNOSPEC INC..
“appointed Mr. Leslie J. Parrette to serve as a Class II director of the Company until the 2022 annual meeting of stockholders of the Company.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.